Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Calliditas Therapeutics AB

Closing information (x1000 NOK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 759,453 Less Arrow 223,664 Less Arrow 916
Financial expenses 35,632 Less Arrow 9,024 More Arrow 59,690
Earnings before taxes -387,273 Less Arrow -500,653 More Arrow -456,912
EBITDA -386,907 Less Arrow -511,461 More Arrow -394,838
Total assets 1,847,342 Less Arrow 1,423,737 More Arrow 1,578,159
Current assets 1,335,822 Less Arrow 987,678 More Arrow 1,086,207
Current liabilities 307,639 Less Arrow 132,090 Less Arrow 110,647
Equity capital 724,818 More Arrow 983,298 More Arrow 1,268,112
- share capital 2,254 Less Arrow 2,042 More Arrow 2,093
Employees (average) 86 Less Arrow 56 Less Arrow 23

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 39.2% More Arrow 69.1% More Arrow 80.4%
Turnover per employee 8,831 Less Arrow 3,994 Less Arrow 40
Profit as a percentage of turnover -51.0% Less Arrow -223.8% Less Arrow -49881.2%
Return on assets (ROA) -19.0% Less Arrow -34.5% More Arrow -25.2%
Current ratio 434.2% More Arrow 747.7% More Arrow 981.7%
Return on equity (ROE) -53.4% More Arrow -50.9% More Arrow -36.0%
Change turnover 542,511 Less Arrow 222,812 Less Arrow -192,712
Change turnover % 250% More Arrow 26141% Less Arrow -100%
Chg. No. of employees 30 More Arrow 33 Less Arrow 9
Chg. No. of employees % 54% More Arrow 143% Less Arrow 64%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.